Drugs

Corticosteroid Resistance and Novel Anti-Inflammatory Therapies in Chronic Obstructive Pulmonary Disease: Current Evidence and Future Direction
pp. 1299-1312(14)
Authors: Hakim, Amir; Adcock, Ian M.; Usmani, Omar S.

Targeting the Glutamatergic System to Treat Major Depressive Disorder: Rationale and Progress to Date
pp. 1313-1333(21)
Authors: Mathews, Daniel C.; Henter, Ioline D.; ZarateJr, Carlos A.

Identification and Therapeutic Management of Highly Sensitized Patients Undergoing Renal Transplantation
pp. 1335-1354(20)
Authors: Huber, Lu; Lachmann, Nils; Dürr, Michael; Matz, Mareen; Liefeldt, Lutz; Neumayer, Hans-H.; Schönemann, Constanze; Budde, Klemens

Intraocular Pressure-Lowering Combination Therapies with Prostaglandin Analogues
pp. 1355-1371(17)
Authors: Aptel, Florent; Chiquet, Christophe; Romanet, Jean-Paul

Heart Failure in Hypertension: Prevention and Treatment
pp. 1373-1398(26)
Authors: Georgiopoulou, Vasiliki V.; Kalogeropoulos, Andreas P.; Butler, Javed

Catumaxomab: In Malignant Ascites
pp. 1399-1410(12)
Author: Frampton, James E.

Mannitol Dry Powder for Inhalation: In Patients with Cystic Fibrosis
pp. 1411-1421(11)
Authors: Burness, Celeste B.; Keating, Gillian M.

Vandetanib: In Medullary Thyroid Cancer
pp. 1423-1436(14)
Author: Frampton, James E.